1308-铜死亡与免疫互作:克服免疫治疗耐药的新策略 episode artwork

EPISODE · Jul 20, 2026 · 22 MIN

1308-铜死亡与免疫互作:克服免疫治疗耐药的新策略

from 聊聊Sci

这些研究揭示了铜死亡(Cuproptosis)与抗肿瘤免疫之间存在的双向促进机制。研究表明,肿瘤细胞发生铜死亡时会释放损伤相关分子模式(DAMPs),从而激活树突状细胞(DCs)并增强 CD8⁺ T细胞的抗癌功能。与此同时,T细胞分泌的干扰素-γ (IFN-γ) 能通过 STAT1-IRF1 信号轴驱动 FDX1 基因的转录,进面显著提高肿瘤细胞对铜死亡的敏感性。基于这一发现,研究者提出将铜死亡诱导剂(如艾利司莫-铜)与 PD-L1 抑制剂联合使用,这种疗法能产生协同效应。实验证明,该联合方案可以有效打破肿瘤微环境的免疫抑制状态,从而克服多种癌症模型对免疫治疗的固有或获得性耐药。此外,FDX1 的表达水平也被证实是预测免疫检查点封锁疗效的重要生物标志物。References:Lei G, Lu Z, Xu Z, et al. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance[J]. Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jul 20, 2026

Embed this episode

Ready to play

1308-铜死亡与免疫互作:克服免疫治疗耐药的新策略

0:00 22:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 22 minutes long.

When was this 聊聊Sci episode published?

This episode was published on July 20, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!